Anterior knee pain that worsens with stairs, squatting, or long periods of sitting is one of the most common reasons people search for treatment for chondromalacia of the patella. Also known as runner’s knee, this condition involves softening and breakdown of the cartilage on the underside of the kneecap, and it can range from a mild nuisance to a persistent barrier to activity. Understanding why this cartilage condition develops, and which treatments have real evidence behind them, can help you make sense of your own symptoms and options.

This article covers the underlying anatomy and causes of chondromalacia, its hallmark warning signs, how the condition is diagnosed and staged, and where regenerative approaches like stem cell therapy fit alongside more conventional care. It also reviews the current research on cell-based treatments so you can weigh the evidence rather than relying on marketing claims alone.

What Is Chondromalacia of the Patella?

Chondromalacia patella refers to progressive damage to the hyaline cartilage that lines the underside of the kneecap, the smooth tissue that normally allows the patella to glide over the femur with minimal friction. According to a StatPearls clinical overview, chondromalacia involves softening of this cartilage that can progress to tearing, fissuring, and erosion over time (Habusta et al., StatPearls, NCBI Bookshelf).

A more recent review in Stem Cell Research & Therapy describes the process in stages, beginning with cartilage that becomes dull, softened, and swollen, and advancing toward fibrillation and surface erosion as the disease progresses (Zheng et al., Stem Cell Research & Therapy, 2021). Because cartilage has limited blood supply and a reduced capacity for self-repair, damage tends to accumulate gradually rather than heal on its own, which is part of why early recognition matters.

Several factors are associated with the development of chondromalacia, including prior trauma to the knee, patellofemoral instability, abnormal patellar tracking, anatomical variations in the trochlear groove, and repetitive loading from running or jumping sports. Excess body weight and quadriceps weakness are also frequently cited contributing factors, since both increase mechanical stress on the patellofemoral joint.

Symptoms of Chondromalacia Patella

The most common symptoms of chondromalacia patella include a dull, aching pain at the front of the knee that intensifies with activities placing load on a bent knee, such as climbing stairs, squatting, kneeling, or sitting for extended periods with the knee flexed, sometimes called the “moviegoer’s sign.” Many people also notice a grinding, clicking, or crackling sensation, known as crepitus, when they bend or straighten the knee.

Other reported signs include mild swelling around the kneecap, a sense of the knee “giving way,” and visible wasting of the quadriceps muscle in longer-standing cases. Symptoms often build gradually rather than appearing suddenly after a single injury, though a fall or direct blow to the kneecap can accelerate the process in some individuals.

Diagnosis and Staging

Diagnosis typically begins with a detailed history and a physical exam that assesses knee alignment, swelling, and tenderness around the kneecap. Clinicians frequently perform the patellar grind test, in which downward pressure is applied to the kneecap during quadriceps contraction, with pain during this maneuver considered a supportive finding.

Imaging is used to confirm the diagnosis and gauge severity. MRI can reveal cartilage softening, surface irregularity, and, in more advanced cases, exposure of the underlying bone. Cartilage damage is commonly graded using a modified Outerbridge classification, which ranges from softened but intact cartilage in earlier grades to full-thickness loss with exposed bone in the most advanced grade. This staging helps guide which treatments, including whether regenerative options are appropriate, are likely to be most beneficial.

Conventional Treatment for Chondromalacia of the Patella

Most cases of chondromalacia respond, at least partially, to conservative, non-surgical care. Standard treatment for chondromalacia of the patella typically starts with activity modification to reduce high-load, repetitive knee flexion, along with structured physical therapy focused on strengthening the quadriceps and hip stabilizers to improve patellar tracking.

Additional conservative measures may include:

• Patellar taping or bracing to support alignment during activity and reduce pain.
• Short-term use of NSAIDs to manage inflammation and discomfort.
• Foot orthotics for individuals with excessive pronation that affects knee mechanics.
• Ice application after activity to help control swelling.

When conservative measures do not provide adequate relief, especially in more advanced cartilage damage, clinicians may consider arthroscopic debridement or, in select cases, surgical realignment procedures. However, these approaches largely aim to manage symptoms and remove damaged tissue rather than regenerate healthy cartilage, which is part of why interest in regenerative medicine has grown.

Stem Cell Therapy for Chondromalacia Patella: What the Evidence Shows

Because mature cartilage has limited capacity for self-repair, researchers have increasingly explored whether stem cell therapy can help address chondromalacia at a biological level rather than simply managing symptoms. Mesenchymal stem cells (MSCs), which can be sourced from bone marrow, adipose tissue, or umbilical cord tissue, are of particular interest because they appear to support cartilage repair through two mechanisms: direct differentiation toward cartilage-forming cells and the release of paracrine signaling factors that may stimulate the body’s own repair processes (Zheng et al., Stem Cell Research & Therapy, 2021).

Early clinical evidence is encouraging, though still limited in scale. In one case series published in PLOS ONE, three patients with chondromalacia patella and anterior knee pain that had not responded to conservative treatment received a series of injections combining autologous adipose-derived stem cells with platelet-rich plasma and hyaluronic acid. Patients reported pain improvement of 50 to 70 percent at one month and 80 to 90 percent at three months, with benefits reportedly maintained through 12-month follow-up and MRI showing evidence of cartilage restoration (Pak, Lee & Lee, PLOS ONE, 2013).

Bone marrow aspirate concentrate (BMAC), which contains a concentrated mix of mesenchymal stem cells and growth factors drawn from a patient’s own bone marrow, has also been studied as a regenerative option. A 2024 case report described a patient with chondromalacia patella who received a single BMAC injection following ultrasound-guided bone marrow aspiration and double centrifugation. Pain scores dropped from 8 to 3 out of 10, and validated knee function scores improved substantially over 12 weeks of follow-up (Soundharya et al., Cureus, 2024).

These findings are promising, but the evidence base for stem cell therapy in chondromalacia patella still consists largely of small case series and case reports rather than large randomized controlled trials. Confidence in the long-term durability and comparative effectiveness of these treatments is therefore considered moderate rather than definitive, and outcomes are likely to vary based on cartilage damage severity, the stem cell source used, and individual patient factors.

Is Stem Cell Therapy Right for You?

Stem cell therapy is generally considered for patients with persistent anterior knee pain from chondromalacia who have not achieved adequate relief from structured physical therapy and activity modification, particularly when imaging shows early to moderate cartilage changes rather than complete cartilage loss. It is typically administered as an in-office injection procedure using a patient’s own cells, which may reduce certain risks associated with donor tissue.

As with any regenerative procedure, candidacy depends on individual factors such as the stage of cartilage damage, overall joint alignment, and other health conditions. A qualified clinician can review imaging and history to determine whether stem cell therapy, PRP, or a combination approach is a reasonable option, and to set realistic expectations about the pace and extent of improvement.

Frequently Asked Questions

What is chondromalacia of the patella?

Chondromalacia of the patella is a condition involving softening and progressive breakdown of the cartilage under the kneecap, often called runner’s knee. It develops gradually and is associated with factors such as patellar instability, repetitive impact, and quadriceps weakness.

What are the main symptoms of chondromalacia patella?

The main warning signs are dull anterior knee pain that worsens with stairs, squatting, or prolonged sitting, along with grinding or clicking sensations in the knee. Mild swelling and a feeling of knee instability may also occur.

How is chondromalacia patella diagnosed?

Diagnosis combines a physical exam, including the patellar grind test, with imaging such as MRI to assess cartilage condition. Cartilage damage is often staged using a modified Outerbridge classification to guide treatment decisions.

Can chondromalacia patella heal without surgery?

Many cases improve substantially with conservative treatment, including targeted physical therapy, activity modification, and bracing or taping. Surgery is generally reserved for cases that do not respond adequately to non-surgical care.

How does stem cell therapy work for chondromalacia?

Stem cell therapy uses a patient’s own mesenchymal stem cells, often from bone marrow or fat tissue, injected into the knee joint. These cells may support cartilage repair through direct differentiation and by releasing factors that encourage the body’s natural healing response.

Is stem cell treatment for chondromalacia patella safe?

Available case series and case reports have generally reported no serious adverse effects from autologous stem cell or BMAC injections for chondromalacia. Because the evidence base is still developing, safety and outcomes should be discussed individually with a treating clinician.

How long does it take to see results from stem cell therapy?

In published case reports, patients have reported meaningful pain improvement within one to three months of treatment, with some benefits maintained through 12 months of follow-up. Individual timelines can vary based on cartilage damage severity and overall health.

Key Takeaways

• Chondromalacia patella involves progressive softening and breakdown of cartilage under the kneecap and is a common cause of anterior knee pain.
• Common warning signs include aching anterior knee pain with stairs or squatting, crepitus, and occasional swelling.
• Diagnosis relies on physical exam findings and MRI, with cartilage damage often staged using a modified Outerbridge classification.
• Conventional treatment for chondromalacia of the patella starts with physical therapy, activity changes, and supportive bracing before more invasive options are considered.
• Early research on mesenchymal stem cell therapy, including adipose-derived cells and BMAC, has shown encouraging pain and function improvements in small case series.
• The regenerative medicine evidence base is still developing, so candidacy for stem cell therapy should be evaluated individually with a qualified clinician.

Schedule a Consultation

If conservative care has not resolved your anterior knee pain, Ways2Well’s stem cell therapy programs can help you understand whether regenerative treatment is a reasonable next step for your chondromalacia. Schedule a consultation to discuss your imaging, symptoms, and treatment history with a clinician.

For related reading, see Ways2Well’s guides on nonsurgical knee cartilage injury treatment options and MUSE stem cells: reality or just a myth.

Sources

• Habusta ST, Coffey R, Ponnarasu S, et al. Chondromalacia Patella. StatPearls, NCBI Bookshelf.
• Zheng W, Li H, Hu K, Li L, Bei M. Chondromalacia patellae: current options and emerging cell therapies. Stem Cell Research & Therapy, 2021.
• Pak J, Lee JH, Lee SH. A Novel Biological Approach to Treat Chondromalacia Patellae. PLOS ONE, 2013.
• Soundharya V, Arthi R, Hari Haran, Suresh Kumar I, Sahayaraj James. Enhanced Bone Marrow Aspirate Concentrate (BMAC) Preparation Strategy in the Management of Chondromalacia Patella: A Case Report. Cureus, 2024.

Author: Ways2Well Editorial Team

Reviewed by: Scientific Advisory Board member